Role of CYP epoxygenases in A_2AAR-mediated relaxation using A_2AAR-null and wild-type mice

Medicine & Life Sciences

• Adenosine A2A Receptors 100%
• Cytochrome P-450 Enzyme System 69%
• Aorta 44%
• Adenosine-5'-(N-ethylcarboxamide) 30%
• Endothelium 9%
• Acids 7%
• N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine 6%
• 14,15-episulfide eicosatrienoic acid 6%
• 14,15-dihydroxyeicosatrienoic acid 6%
• 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine 5%
• Adenosine A2 Receptor Antagonists 5%
• Cytochrome P-450 Enzyme Inhibitors 5%
• 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine 5%
• arginine methyl ester 4%
• Cyclooxygenase Inhibitors 4%
• Nitric Oxide Synthase Type III 3%
• Mixed Function Oxygenases 3%
• Vasoconstriction 3%
• Indomethacin 3%
• Adenosine 3%
• Vasodilation 3%
• Proteins 1%